Integrated BioPharma Inc (INBP) income statement
INBPOTCPharmaceutical PreparationsFiscal year ends June 30
Số liệu tài chính tới Q4 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$0.18+0.00 (0.00%)
Close on Oct 19, 2026Market cap $5.59MP/E –Yield –
Integrated BioPharma Inc income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 1.8%
- Operating margin
- -6.2%
- Net margin
- -6.5%
- Return on equity, FY2026
- -15.0%
Financial strength
- Current ratio
- 3.00
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 77.1%
Valuation
- P/E ratio
- –
- Price to sales
- 0.13
- Price to book
- 0.32
- Dividend yield
- –
See a number that looks wrong?